2026 ICD-10-CM Diagnosis Code E88.01Alpha-1-antitrypsin deficiency

ICD-10-CM CodesE00–E89E70-E88E88

ICD-10-CM E88.01
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

E88.01 is a billable ICD-10-CM diagnosis code for Alpha-1-antitrypsin deficiency. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.

Code Identity

ICD-10-CM Code
E88.01
Billable Status
Yes — Valid for Submission
Code Describes
Alpha-1-antitrypsin deficiency
Short Description
Alpha-1-antitrypsin deficiency
Same as the full description in the CMS dataset.
Parent Code
Disorders of plasma-protein metabolism, not elsewhere classified

Code Classification

ChapterE00–E89Endocrine, nutritional and metabolic diseases
SectionE70-E88Metabolic disorders
CategoryE88Other and unspecified metabolic disorders
This CodeE88.01Alpha-1-antitrypsin deficiency

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Alpha-1-antitrypsin deficiency
  • Alpha-1-antitrypsin hepatitis
  • Panniculitis due to action of lipolytic enzymes
  • Panniculitis due to alpha-1 anti-trypsin deficiency
  • Pulmonary emphysema in alpha-1 PI deficiency

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • AAT deficiency

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Deficiency, deficient
      • alpha-1-antitrypsin
    • Deficiency, deficient
      • serum antitrypsin, familial

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR END016
Other specified and unspecified nutritional and metabolic disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Patient EducationClinical

Alpha-1 Antitrypsin Deficiency

Alpha-1 antitrypsin deficiency (AAT deficiency, or AATD) is an inherited condition that raises your risk for lung and liver disease. If you have this condition, your body doesn't make enough alpha-1 antitrypsin (AAT).

The full article covers:

  • What is alpha-1 antitrypsin deficiency (AAT deficiency)?
  • What causes alpha-1 antitrypsin deficiency (AAT deficiency)?
  • What are the symptoms of alpha-1 antitrypsin deficiency (AAT deficiency)?
  • How is alpha-1 antitrypsin deficiency (AAT deficiency) diagnosed?
  • What are the treatments for alpha-1 antitrypsin deficiency (AAT deficiency)?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert E88.01 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
273.4 Alpha-1-antitrypsin def
Exact Match The mapping is direct, with no qualifiers.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About E88.01Overview

Is E88.01 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report Alpha-1-antitrypsin deficiency on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of E88.01?

Under the General Equivalence Mappings, Alpha-1-antitrypsin deficiency converts to ICD-9-CM 273.4 (Alpha-1-antitrypsin def). The mapping is a direct match.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.